Friday, 26 May 2017

Korea News

  • Samsung's Humira biosimilar accepted for review by EU

    Korea |  News | By BioSpectrum Bureau | 0 Comment

    Singapore: Korean drug giant Samsung Bioepis, recently revealed that it is seeking regulatory approval in Europe to sell its copy of AbbVie Inc's rheumatoid arthritis drug Humira. The compa...Read more

  • Daiichi Sankyo inks marketing pact with Daewoong Pharmaceutical

    Korea |  News | By BioSpectrum Bureau | 0 Comment

    Singapore: Daiichi Sankyo Company has announced that its wholly owned subsidiary, Daiichi Sankyo Korea and Daewoong Pharmaceutical have signed an agreement for the co-promotion of the oral,...Read more

  • China Cord Blood, Cordlife join hands for stem cell therapy services

    Korea |  News | By BioSpectrum Bureau | 0 Comment

    Singapore: China Cord Blood Corporation (CCBC) and Cordlife Group, a multi-product healthcare company catering to the mother and child segment, have come together to assist patients across ...Read more

  • Korea to nurture pharma sector with capital assistance

    Korea |  News | By BioSpectrum Bureau | 0 Comment

    Singapore: The Korean Ministry of health and welfare have announced the start of second phase of Global Pharmaceutical Industry Development Fund worth 135 billion won (US$123 million) to nu...Read more

  • Amgen to acquire rights of three drugs from GSK

    Korea |  News | By BioSpectrum Bureau | 0 Comment

    Singapore: Global pharmaceutical company, Amgen, has plans to reacquire all of its remaining rights from GSK on Prolia (denosumab), XGEVA (denosumab) and Vectibix (panitumumab) in 48 countr...Read more

  • Asia's lung cancer burden

    Korea |  Analysis | By Amrita Tejasvi | 0 Comment

    Lung cancer occurs in two types, small cell lung cancer and the more prevalent non-small scale lung cancer. According to oncology specialists' analysis, 85 percent of the lung cancer patien...Read more

  • Biosimilars to push growth in China, Korea, India

    Korea |  News | By BioSpectrum Bureau | 0 Comment

    Singapore: The annual revenue for biopharmaceuticals has been consistently growing since 2001, accounting for 15.6 percent of the total pharmaceutical market in 2011. The global biopharmac...Read more

  • Bayer Korea appoints a new CEO

    Korea |  News | By BioSpectrum Bureau | 0 Comment

    Singapore: Bayer Korea recently announced the appointment of Ms Ingrid Drechsel as its new CEO. The company said in a statement that Ms Drechsel will manage Bayer's business units in Korea ...Read more

  • TWi Biotech secures patent for diabetes drug in Korea

    Korea |  News | By BioSpectrum Bureau | 0 Comment

    Singapore: Taiwan based TWi Biotechnology has been granted patent in Korea for it diabetes drug, AC-201, from the Korean Intellectual Property Office. The patent includes AC-201 or its pha...Read more

  • Korea's Green cross expands cell therapy business in China

    Korea |  News | By BioSpectrum Bureau | 0 Comment

    Singapore: South Korean biopharmaceutical company, Green Cross, is expanding its presence in China by building a cell therapy facility to produce and distribute cell therapy products in the...Read more

  • Singapore, Korea partner to boost innovation in MedTech

    Korea |  News | By BioSpectrum Bureau | 0 Comment

    Singapore: Singapore-Stanford Biodesign (SSB) has inked a three-year pact with Korea's Dongguk University (DU) to train and develop skilled talent in innovative medical technologies. The de...Read more

  • Korean President rolls out plans to beef up biotech sector

    Korea |  News | By BioSpectrum Bureau | 0 Comment

    Singapore: With a view to bolster the country's burgeoning biotech sector, the South Korean government recently announced a series of comprehensive plans to ease regulations in its biotech ...Read more

  • Top 20: SOUTH KOREA - Registers 5% Growth

    Korea |  Analysis | By BioSpectrum Bureau | 0 Comment

    South Korean publicly listed bioscience companies in 2013 registered combined revenue of $8.3 billion. The leading publicly listed bioscience company in South Korea, Yuhan Corporation, c...Read more

  • Anteo Diagnostic to enter Korea market

    Korea |  News | By BioSpectrum Bureau | 0 Comment

    Singapore: Australia based global medical technology company, Anteo Diagnostics, has entered into a non-exclusive distribution agreement with KomaBiotech, a Korean manufacturer and supplier...Read more

  • Novartis in bribery scandal again,this time in Korea

    Korea |  News | By BioSpectrum Bureau | 0 Comment

    Singapore:The latest in a string of scandals related to Novartis comes from Korea. As reported by the Korean Herald, six incumbent and former executives of the South Korean unit of Swiss ph...Read more

  • Seegene develops real-time array to fuel POCT

    Korea |  News | By BioSpectrum Bureau | 0 Comment

    Singapore: Seegene has developed a novel real-time array technology designed specifically to accelerate the development of Point of Care Testing (POCT). The novel real-time array technology...Read more

  • Asian endoscopy market clocked $264.7 mn in 2012

    Korea |  News | By BioSpectrum Bureau | 0 Comment

    Singapore: Endoscopy devices market in Australia, South Korea, and Southeast Asia, earned revenues of USD264.7 million in 2012 and estimates this to reach USD408.3 million in 2017, accordin...Read more

  • Korea's LSK Global strengthens ties with Medidata

    Korea |  News | By BioSpectrum Bureau | 0 Comment

    Singapore: Korea's leading CRO, LSK Global has expanded its use of Medidata Clinical cloud platform, thus strengthening its global R&D capabilities. The Seoul based organization was est...Read more

Survey Box

Will biobanking change healthcare in the world?

× Please select an option to participate in the poll.
Processing...   View poll results   More polls

× You have successfully cast your vote.
{{ optionDetail.option }}{{ optionDetail.percentage }}%
{{ optionDetail.percentage }}% Complete
More polls